Try our beta test site
1 study found for:    21273939 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Immunogenicity and Safety of GlaxoSmithKline Biologicals' Huma Papillomavirus (HPV) Vaccine 580299 in Healthy Females 15 - 25 Years of Age
Condition: Infections, Papillomavirus
Intervention: Biological: Cervarix TM

Study has passed its completion date and status has not been verified in more than two years.